Viral hepatitis in incarcerated adults: a medical and public health concern.
Viral hepatitis is a common problem in the incarcerated population. It causes significant morbidity and mortality, and incarcerated inmates receive their health care almost exclusively from corrections-based health systems. The seroprevalence of hepatitis B and C infections is increased in this population, and a number of risk factors for viral hepatitis are particularly common and infer higher risk among inmates, including injection drug use (IDU), high-risk sexual activity, and tattoos. IDU, in particular, has been identified as an important and common risk factor for viral hepatitis in inmates, and variable rates of IDU among inmates have been found to be the most important cause of the marked variability of seroprevalence rates for exposure to hepatitis C virus. A number of risk reduction and management strategies have been identified that can decrease transmission to other inmates. Prison-based hepatitis A and hepatitis B vaccination programs, needle exchange programs, methadone maintenance programs, risk education programs, and hepatitis C virus antiviral programs, for example, have been shown to be safe and effective risk reduction and management strategies. Preliminary studies have shown that these strategies are underutilized in the United States. Reasons for this phenomenon are multifactorial, involving financial as well as ethical and political considerations. Additional funding, research, and formal consideration / discussion of the complex issues involving viral hepatitis in the US incarcerated population are clearly important for the sake of inmates and the community at large. In this article, the published medical literature regarding this important topic is reviewed.
Hunt
Douglas R
DR
Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Saab
Sammy
S
D000328:Adult; D018562:Disease Transmission, Infectious / Q000517:prevention & control / Q000706:statistics & numerical data; D006525:Hepatitis, Viral, Human / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D009017:Morbidity / Q000639:trends; D011329:Prisoners; D011634:Public Health; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D015996:Survival Rate / Q000639:trends; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000379:methods*; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*
D014761:Viral Hepatitis Vaccines